Gokul Refoils and Solvent Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 3, 2025, 8:48 pm

Competitors of Gokul Refoils and Solvent Ltd

All Competitor Stocks of Gokul Refoils and Solvent Ltd

Quarterly Result

Last Updated: August 20, 2025, 10:15 am

Below is a detailed analysis of the quarterly data for Gokul Refoils and Solvent Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 926.43 Cr.. The value appears strong and on an upward trend. It has increased from 860.07 Cr. (Mar 2025) to 926.43 Cr., marking an increase of 66.36 Cr..
• For Expenses, as of Jun 2025, the value is 912.58 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 850.74 Cr. (Mar 2025) to 912.58 Cr., marking an increase of 61.84 Cr..
• For Operating Profit, as of Jun 2025, the value is 13.85 Cr.. The value appears strong and on an upward trend. It has increased from 9.33 Cr. (Mar 2025) to 13.85 Cr., marking an increase of 4.52 Cr..
• For OPM %, as of Jun 2025, the value is 1.49%. The value appears strong and on an upward trend. It has increased from 1.08% (Mar 2025) to 1.49%, marking an increase of 0.41%.
• For Other Income, as of Jun 2025, the value is 2.97 Cr.. The value appears to be declining and may need further review. It has decreased from 10.23 Cr. (Mar 2025) to 2.97 Cr., marking a decrease of 7.26 Cr..
• For Interest, as of Jun 2025, the value is 8.81 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.79 Cr. (Mar 2025) to 8.81 Cr., marking an increase of 1.02 Cr..
• For Depreciation, as of Jun 2025, the value is 2.71 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.02 Cr. (Mar 2025) to 2.71 Cr., marking a decrease of 0.31 Cr..
• For Profit before tax, as of Jun 2025, the value is 5.30 Cr.. The value appears to be declining and may need further review. It has decreased from 8.75 Cr. (Mar 2025) to 5.30 Cr., marking a decrease of 3.45 Cr..
• For Tax %, as of Jun 2025, the value is 27.36%. The value appears to be increasing, which may not be favorable. It has increased from 24.11% (Mar 2025) to 27.36%, marking an increase of 3.25%.
• For Net Profit, as of Jun 2025, the value is 3.86 Cr.. The value appears to be declining and may need further review. It has decreased from 6.64 Cr. (Mar 2025) to 3.86 Cr., marking a decrease of 2.78 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.39. The value appears to be declining and may need further review. It has decreased from 0.67 (Mar 2025) to 0.39, marking a decrease of 0.28.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:17 am

Growth

Last Updated: September 5, 2025, 5:10 am

Balance Sheet

Last Updated: August 11, 2025, 4:32 pm

Below is a detailed analysis of the balance sheet data for Gokul Refoils and Solvent Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 20.00 Cr..
• For Reserves, as of Mar 2025, the value is 325.00 Cr.. The value appears strong and on an upward trend. It has increased from 310.00 Cr. (Mar 2024) to 325.00 Cr., marking an increase of 15.00 Cr..
• For Borrowings, as of Mar 2025, the value is 280.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 282.00 Cr. (Mar 2024) to 280.00 Cr., marking a decrease of 2.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 143.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 127.00 Cr. (Mar 2024) to 143.00 Cr., marking an increase of 16.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 768.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 739.00 Cr. (Mar 2024) to 768.00 Cr., marking an increase of 29.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 113.00 Cr.. The value appears strong and on an upward trend. It has increased from 108.00 Cr. (Mar 2024) to 113.00 Cr., marking an increase of 5.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 7.00 Cr..
• For Investments, as of Mar 2025, the value is 43.00 Cr.. The value appears to be declining and may need further review. It has decreased from 60.00 Cr. (Mar 2024) to 43.00 Cr., marking a decrease of 17.00 Cr..
• For Other Assets, as of Mar 2025, the value is 612.00 Cr.. The value appears strong and on an upward trend. It has increased from 564.00 Cr. (Mar 2024) to 612.00 Cr., marking an increase of 48.00 Cr..
• For Total Assets, as of Mar 2025, the value is 768.00 Cr.. The value appears strong and on an upward trend. It has increased from 739.00 Cr. (Mar 2024) to 768.00 Cr., marking an increase of 29.00 Cr..

Notably, the Reserves (325.00 Cr.) exceed the Borrowings (280.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Gokul Refoils and Solvent Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.50. This value is below the healthy minimum of 5. It has increased from 0.18 (Mar 24) to 1.50, marking an increase of 1.32.
• For Diluted EPS (Rs.), as of Mar 25, the value is 1.50. This value is below the healthy minimum of 5. It has increased from 0.18 (Mar 24) to 1.50, marking an increase of 1.32.
• For Cash EPS (Rs.), as of Mar 25, the value is 2.67. This value is below the healthy minimum of 3. It has increased from 1.23 (Mar 24) to 2.67, marking an increase of 1.44.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 34.81. It has increased from 33.33 (Mar 24) to 34.81, marking an increase of 1.48.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 34.81. It has increased from 33.33 (Mar 24) to 34.81, marking an increase of 1.48.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 354.65. It has increased from 305.05 (Mar 24) to 354.65, marking an increase of 49.60.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 6.55. This value is within the healthy range. It has increased from 6.54 (Mar 24) to 6.55, marking an increase of 0.01.
• For PBIT / Share (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. It has decreased from 5.49 (Mar 24) to 5.37, marking a decrease of 0.12.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.00. This value is within the healthy range. It has increased from 0.26 (Mar 24) to 2.00, marking an increase of 1.74.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.50. This value is below the healthy minimum of 2. It has increased from 0.18 (Mar 24) to 1.50, marking an increase of 1.32.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.50. This value is below the healthy minimum of 2. It has increased from 0.18 (Mar 24) to 1.50, marking an increase of 1.32.
• For PBDIT Margin (%), as of Mar 25, the value is 1.84. This value is below the healthy minimum of 10. It has decreased from 2.14 (Mar 24) to 1.84, marking a decrease of 0.30.
• For PBIT Margin (%), as of Mar 25, the value is 1.51. This value is below the healthy minimum of 10. It has decreased from 1.79 (Mar 24) to 1.51, marking a decrease of 0.28.
• For PBT Margin (%), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 10. It has increased from 0.08 (Mar 24) to 0.56, marking an increase of 0.48.
• For Net Profit Margin (%), as of Mar 25, the value is 0.42. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.42, marking an increase of 0.36.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.42. This value is below the healthy minimum of 8. It has increased from 0.06 (Mar 24) to 0.42, marking an increase of 0.36.
• For Return on Networth / Equity (%), as of Mar 25, the value is 4.29. This value is below the healthy minimum of 15. It has increased from 0.54 (Mar 24) to 4.29, marking an increase of 3.75.
• For Return on Capital Employeed (%), as of Mar 25, the value is 14.65. This value is within the healthy range. It has decreased from 15.42 (Mar 24) to 14.65, marking a decrease of 0.77.
• For Return On Assets (%), as of Mar 25, the value is 1.92. This value is below the healthy minimum of 5. It has increased from 0.24 (Mar 24) to 1.92, marking an increase of 1.68.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.04 (Mar 24) to 0.02, marking a decrease of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.80. This value is within the healthy range. It has decreased from 1.00 (Mar 24) to 0.80, marking a decrease of 0.20.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 4.66. It has increased from 3.82 (Mar 24) to 4.66, marking an increase of 0.84.
• For Current Ratio (X), as of Mar 25, the value is 1.47. This value is below the healthy minimum of 1.5. There is no change compared to the previous period (Mar 24) which recorded 1.47.
• For Quick Ratio (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.92.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 16.28. This value exceeds the healthy maximum of 8. It has increased from 10.87 (Mar 24) to 16.28, marking an increase of 5.41.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.94. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 24) which recorded 1.94.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 3. It has decreased from 1.61 (Mar 24) to 1.44, marking a decrease of 0.17.
• For Enterprise Value (Cr.), as of Mar 25, the value is 640.34. It has increased from 603.37 (Mar 24) to 640.34, marking an increase of 36.97.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 24) to 0.18, marking a decrease of 0.01.
• For EV / EBITDA (X), as of Mar 25, the value is 9.88. This value is within the healthy range. It has increased from 9.33 (Mar 24) to 9.88, marking an increase of 0.55.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.12. This value is below the healthy minimum of 1. It has increased from 0.11 (Mar 24) to 0.12, marking an increase of 0.01.
• For Price / BV (X), as of Mar 25, the value is 1.23. This value is within the healthy range. It has increased from 1.05 (Mar 24) to 1.23, marking an increase of 0.18.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.12. This value is below the healthy minimum of 1. It has increased from 0.11 (Mar 24) to 0.12, marking an increase of 0.01.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.03, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness